Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global AAV Vector Transfection Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Global AAV Vector Transfection Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-27
Pages: 141 Pages
Report ld: 4937582
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
AAV Vector Transfection Kits Market Size(US$)
CAGR 2025-2031
25.9%
Market Size,2031
USD 872
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 219 million
Market Forecast in 2031(Value)
US$ 872 million
CAGR
25.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AAV Vector Transfection Kits market is projected to grow from US$ 177 million in 2024 to US$ 872 million by 2031, at a CAGR of 25.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research. There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development.
The market for AAV (Adeno-Associated Virus) Vector Transfection Kits is being driven by the rapid growth of gene therapy and cell-based research, particularly in the treatment of genetic disorders, cancers, and neurological diseases. AAV vectors are favored for their low immunogenicity, long-term gene expression, and safety profile, making them a preferred delivery vehicle for therapeutic genes. As clinical pipelines for AAV-based therapies expand, there is increasing demand for efficient, reliable, and scalable transfection kits that can support both research and GMP-compliant manufacturing. Furthermore, the rising number of biotech companies and academic institutions working on gene-editing technologies like CRISPR is fueling adoption of these kits, as researchers seek high transfection efficiency and reproducibility across various cell types and production systems.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AAV Vector Transfection Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher
- Mirus Bio (Gamma)
- Polyplus-transfection
- Polysciences
- Takara
- Hanbio Biotechnology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Small Size Packaging
- Medium Size Packaging
- Large Size Packaging
Segment by Application
- Laboratory
- GMP Phase 1-2
CHAPTER OUTLINE
Chapter 1: Defines the AAV Vector Transfection Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to AAV Vector Transfection Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AAV Vector Transfection Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Small Size Packaging
1.2.3 Medium Size Packaging
1.2.4 Large Size Packaging
1.3 Market Segmentation by Application
1.3.1 Global AAV Vector Transfection Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 GMP Phase 1-2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AAV Vector Transfection Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global AAV Vector Transfection Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global AAV Vector Transfection Kits Sales Estimates and Forecasts 2020-2031
2.4 Global AAV Vector Transfection Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global AAV Vector Transfection Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global AAV Vector Transfection Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Small Size Packaging Market Size by Manufacturers
3.5.2 Medium Size Packaging Market Size by Manufacturers
3.5.3 Large Size Packaging Market Size by Manufacturers
3.6 Global AAV Vector Transfection Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AAV Vector Transfection Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global AAV Vector Transfection Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AAV Vector Transfection Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global AAV Vector Transfection Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America AAV Vector Transfection Kits Sales and Revenue by Type (2020-2031)
6.4 North America AAV Vector Transfection Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AAV Vector Transfection Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe AAV Vector Transfection Kits Sales and Revenue by Type (2020-2031)
7.4 Europe AAV Vector Transfection Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AAV Vector Transfection Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific AAV Vector Transfection Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific AAV Vector Transfection Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific AAV Vector Transfection Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America AAV Vector Transfection Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America AAV Vector Transfection Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AAV Vector Transfection Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa AAV Vector Transfection Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa AAV Vector Transfection Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AAV Vector Transfection Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher
11.1.1 Thermo Fisher Corporation Information
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher AAV Vector Transfection Kits Sales by Product in 2024
11.1.6 Thermo Fisher AAV Vector Transfection Kits Sales by Application in 2024
11.1.7 Thermo Fisher AAV Vector Transfection Kits Sales by Geographic Area in 2024
11.1.8 Thermo Fisher AAV Vector Transfection Kits SWOT Analysis
11.1.9 Thermo Fisher Recent Developments
11.2 Mirus Bio (Gamma)
11.2.1 Mirus Bio (Gamma) Corporation Information
11.2.2 Mirus Bio (Gamma) Business Overview
11.2.3 Mirus Bio (Gamma) AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.2.4 Mirus Bio (Gamma) AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mirus Bio (Gamma) AAV Vector Transfection Kits Sales by Product in 2024
11.2.6 Mirus Bio (Gamma) AAV Vector Transfection Kits Sales by Application in 2024
11.2.7 Mirus Bio (Gamma) AAV Vector Transfection Kits Sales by Geographic Area in 2024
11.2.8 Mirus Bio (Gamma) AAV Vector Transfection Kits SWOT Analysis
11.2.9 Mirus Bio (Gamma) Recent Developments
11.3 Polyplus-transfection
11.3.1 Polyplus-transfection Corporation Information
11.3.2 Polyplus-transfection Business Overview
11.3.3 Polyplus-transfection AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.3.4 Polyplus-transfection AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Polyplus-transfection AAV Vector Transfection Kits Sales by Product in 2024
11.3.6 Polyplus-transfection AAV Vector Transfection Kits Sales by Application in 2024
11.3.7 Polyplus-transfection AAV Vector Transfection Kits Sales by Geographic Area in 2024
11.3.8 Polyplus-transfection AAV Vector Transfection Kits SWOT Analysis
11.3.9 Polyplus-transfection Recent Developments
11.4 Polysciences
11.4.1 Polysciences Corporation Information
11.4.2 Polysciences Business Overview
11.4.3 Polysciences AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.4.4 Polysciences AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Polysciences AAV Vector Transfection Kits Sales by Product in 2024
11.4.6 Polysciences AAV Vector Transfection Kits Sales by Application in 2024
11.4.7 Polysciences AAV Vector Transfection Kits Sales by Geographic Area in 2024
11.4.8 Polysciences AAV Vector Transfection Kits SWOT Analysis
11.4.9 Polysciences Recent Developments
11.5 Takara
11.5.1 Takara Corporation Information
11.5.2 Takara Business Overview
11.5.3 Takara AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.5.4 Takara AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Takara AAV Vector Transfection Kits Sales by Product in 2024
11.5.6 Takara AAV Vector Transfection Kits Sales by Application in 2024
11.5.7 Takara AAV Vector Transfection Kits Sales by Geographic Area in 2024
11.5.8 Takara AAV Vector Transfection Kits SWOT Analysis
11.5.9 Takara Recent Developments
11.6 Hanbio Biotechnology
11.6.1 Hanbio Biotechnology Corporation Information
11.6.2 Hanbio Biotechnology Business Overview
11.6.3 Hanbio Biotechnology AAV Vector Transfection Kits Product Models, Descriptions and Specifications
11.6.4 Hanbio Biotechnology AAV Vector Transfection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hanbio Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 AAV Vector Transfection Kits Industry Chain
12.2 AAV Vector Transfection Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 AAV Vector Transfection Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 AAV Vector Transfection Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AAV Vector Transfection Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AAV Vector Transfection Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global AAV Vector Transfection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AAV Vector Transfection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AAV Vector Transfection Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AAV Vector Transfection Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global AAV Vector Transfection Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Liter)
Table 7. Global AAV Vector Transfection Kits Sales by Region (2020-2025) & (Liter)
Table 8. Global AAV Vector Transfection Kits Sales by Region (2026-2031) & (Liter)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global AAV Vector Transfection Kits Sales by Manufacturers (2020-2025) & (Liter)
Table 11. Global AAV Vector Transfection Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global AAV Vector Transfection Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global AAV Vector Transfection Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global AAV Vector Transfection Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Vector Transfection Kits as of 2024)
Table 16. Global AAV Vector Transfection Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global AAV Vector Transfection Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/mL)
Table 18. Key Manufacturers AAV Vector Transfection Kits Manufacturing Base and Headquarters
Table 19. Global AAV Vector Transfection Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global AAV Vector Transfection Kits Sales by Type (2020-2025) & (Liter)
Table 23. Global AAV Vector Transfection Kits Sales by Type (2026-2031) & (Liter)
Table 24. Global AAV Vector Transfection Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global AAV Vector Transfection Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global AAV Vector Transfection Kits ASP by Type (2020-2031) & (US$/mL)
Table 27. Technical Specifications by Key Product Type
Table 28. Global AAV Vector Transfection Kits Sales by Application (2020-2025) & (Liter)
Table 29. Global AAV Vector Transfection Kits Sales by Application (2026-2031) & (Liter)
Table 30. AAV Vector Transfection Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global AAV Vector Transfection Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global AAV Vector Transfection Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global AAV Vector Transfection Kits ASP by Application (2020-2031) & (US$/mL)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America AAV Vector Transfection Kits Growth Accelerators and Market Barriers
Table 37. North America AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America AAV Vector Transfection Kits Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 39. Europe AAV Vector Transfection Kits Growth Accelerators and Market Barriers
Table 40. Europe AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe AAV Vector Transfection Kits Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific AAV Vector Transfection Kits Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific AAV Vector Transfection Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America AAV Vector Transfection Kits Investment Opportunities and Key Challenges
Table 47. Central and South America AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa AAV Vector Transfection Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa AAV Vector Transfection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Corporation Information
Table 51. Thermo Fisher Description and Major Businesses
Table 52. Thermo Fisher Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher AAV Vector Transfection Kits SWOT Analysis
Table 58. Thermo Fisher Recent Developments
Table 59. Mirus Bio (Gamma) Corporation Information
Table 60. Mirus Bio (Gamma) Description and Major Businesses
Table 61. Mirus Bio (Gamma) Product Models, Descriptions and Specifications
Table 62. Mirus Bio (Gamma) Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 63. Mirus Bio (Gamma) Sales Value Proportion by Product in 2024
Table 64. Mirus Bio (Gamma) Sales Value Proportion by Application in 2024
Table 65. Mirus Bio (Gamma) Sales Value Proportion by Geographic Area in 2024
Table 66. Mirus Bio (Gamma) AAV Vector Transfection Kits SWOT Analysis
Table 67. Mirus Bio (Gamma) Recent Developments
Table 68. Polyplus-transfection Corporation Information
Table 69. Polyplus-transfection Description and Major Businesses
Table 70. Polyplus-transfection Product Models, Descriptions and Specifications
Table 71. Polyplus-transfection Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 72. Polyplus-transfection Sales Value Proportion by Product in 2024
Table 73. Polyplus-transfection Sales Value Proportion by Application in 2024
Table 74. Polyplus-transfection Sales Value Proportion by Geographic Area in 2024
Table 75. Polyplus-transfection AAV Vector Transfection Kits SWOT Analysis
Table 76. Polyplus-transfection Recent Developments
Table 77. Polysciences Corporation Information
Table 78. Polysciences Description and Major Businesses
Table 79. Polysciences Product Models, Descriptions and Specifications
Table 80. Polysciences Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 81. Polysciences Sales Value Proportion by Product in 2024
Table 82. Polysciences Sales Value Proportion by Application in 2024
Table 83. Polysciences Sales Value Proportion by Geographic Area in 2024
Table 84. Polysciences AAV Vector Transfection Kits SWOT Analysis
Table 85. Polysciences Recent Developments
Table 86. Takara Corporation Information
Table 87. Takara Description and Major Businesses
Table 88. Takara Product Models, Descriptions and Specifications
Table 89. Takara Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 90. Takara Sales Value Proportion by Product in 2024
Table 91. Takara Sales Value Proportion by Application in 2024
Table 92. Takara Sales Value Proportion by Geographic Area in 2024
Table 93. Takara AAV Vector Transfection Kits SWOT Analysis
Table 94. Takara Recent Developments
Table 95. Hanbio Biotechnology Corporation Information
Table 96. Hanbio Biotechnology Description and Major Businesses
Table 97. Hanbio Biotechnology Product Models, Descriptions and Specifications
Table 98. Hanbio Biotechnology Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 99. Hanbio Biotechnology Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. AAV Vector Transfection Kits Product Picture
Figure 2. Global AAV Vector Transfection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Small Size Packaging Product Picture
Figure 4. Medium Size Packaging Product Picture
Figure 5. Large Size Packaging Product Picture
Figure 6. Global AAV Vector Transfection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Laboratory
Figure 8. GMP Phase 1-2
Figure 9. AAV Vector Transfection Kits Report Years Considered
Figure 10. Global AAV Vector Transfection Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 12. Global AAV Vector Transfection Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global AAV Vector Transfection Kits Revenue Market Share by Region (2020-2031)
Figure 14. Global AAV Vector Transfection Kits Sales (2020-2031) & (Liter)
Figure 15. Global AAV Vector Transfection Kits Sales (CAGR) by Region (2020-2031) (Liter)
Figure 16. Global AAV Vector Transfection Kits Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers AAV Vector Transfection Kits Sales Volume Market Share in 2024
Figure 18. Global AAV Vector Transfection Kits Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Small Size Packaging Revenue Market Share by Manufacturer in 2024
Figure 21. Medium Size Packaging Revenue Market Share by Manufacturer in 2024
Figure 22. Large Size Packaging Revenue Market Share by Manufacturer in 2024
Figure 23. Global AAV Vector Transfection Kits Sales Market Share by Type (2020-2031)
Figure 24. Global AAV Vector Transfection Kits Revenue Market Share by Type (2020-2031)
Figure 25. Global AAV Vector Transfection Kits Sales Market Share by Application (2020-2031)
Figure 26. Global AAV Vector Transfection Kits Revenue Market Share by Application (2020-2031)
Figure 27. North America AAV Vector Transfection Kits Sales YoY (2020-2031) & (Liter)
Figure 28. North America AAV Vector Transfection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers AAV Vector Transfection Kits Sales Revenue (US$ Million) in 2024
Figure 30. North America AAV Vector Transfection Kits Sales Volume (Liter) by Type (2020- 2031)
Figure 31. North America AAV Vector Transfection Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America AAV Vector Transfection Kits Sales Volume (Liter) by Application (2020-2031)
Figure 33. North America AAV Vector Transfection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 35. Canada AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 37. Europe AAV Vector Transfection Kits Sales YoY (2020-2031) & (Liter)
Figure 38. Europe AAV Vector Transfection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers AAV Vector Transfection Kits Sales Revenue (US$ Million) in 2024
Figure 40. Europe AAV Vector Transfection Kits Sales Volume (Liter) by Type (2020-2031)
Figure 41. Europe AAV Vector Transfection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe AAV Vector Transfection Kits Sales Volume (Liter) by Application (2020-2031)
Figure 43. Europe AAV Vector Transfection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 45. France AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 47. Italy AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 48. Russia AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific AAV Vector Transfection Kits Sales YoY (2020-2031) & (Liter)
Figure 50. Asia-Pacific AAV Vector Transfection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers AAV Vector Transfection Kits Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific AAV Vector Transfection Kits Sales Volume (Liter) by Type (2020- 2031)
Figure 53. Asia-Pacific AAV Vector Transfection Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific AAV Vector Transfection Kits Sales Volume (Liter) by Application (2020-2031)
Figure 55. Asia-Pacific AAV Vector Transfection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 57. Japan AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 60. India AAV Vector Transfection Kits Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America AAV Vector Transfection Kits Sales YoY (2020-2031) & (Liter)
Figure 62. Central and South America AAV Vector Transfection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers AAV Vector Transfection Kits Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America AAV Vector Transfection Kits Sales Volume (Liter) by Type (2021-2031)
Figure 65. Central and South America AAV Vector Transfection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America AAV Vector Transfection Kits Sales Volume (Liter) by Application (2020-2031)
Figure 67. Central and South America AAV Vector Transfection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa AAV Vector Transfection Kits Sales YoY (2020-2031) & (Liter)
Figure 71. Middle East and Africa AAV Vector Transfection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers AAV Vector Transfection Kits Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa AAV Vector Transfection Kits Sales Volume (Liter) by Type (2021-2031)
Figure 74. South America AAV Vector Transfection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa AAV Vector Transfection Kits Sales Volume (Liter) by Application (2020-2031)
Figure 76. Middle East and Africa AAV Vector Transfection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa AAV Vector Transfection Kits Revenue (2020-2025) & (US$ Million)
Figure 81. AAV Vector Transfection Kits Industry Chain Mapping
Figure 82. Regional AAV Vector Transfection Kits Manufacturing Base Distribution (%)
Figure 83. Global AAV Vector Transfection Kits Production Market Share by Region (2020-2031)
Figure 84. AAV Vector Transfection Kits Production Process
Figure 85. Regional AAV Vector Transfection Kits Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 25.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global AAV Vector Transfection Kits market size from 2025 to 2031?
What was the global market size of AAV Vector Transfection Kits in 2031?
What was the global market size of AAV Vector Transfection Kits in 2025?
Which companies rank high in the global AAV Vector Transfection Kits market?
Related Reports
Global AAV Vector Transfection Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AAV Vector Transfection Kits market size was US$ 219 million in 2025 and is forecast to reach a readjusted size of US$ 1076 million by 2032 with a CAGR of 25.9% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 76
USD 4250.00
(Single User License)
Global AAV Vector Transfection Kits Market Research Report 2026
The global AAV Vector Transfection Kits market was valued at US$ 219 million in 2025 and is anticipated to reach US$ 1076 million by 2032, at a CAGR of 25.9% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 108
USD 2900.00
(Single User License)
AAV Vector Transfection Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 219 million in 2025 and is projected to reach US$ 1076 million, growing at a CAGR of 25.9% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 108
USD 3950.00
(Single User License)
AAV Vector Transfection Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 177 million in 2024 and is forecast to a readjusted size of US$ 872 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 102
USD 3950.00
(Single User License)
Global AAV Vector Transfection Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AAV Vector Transfection Kits market size was US$ 177 million in 2024 and is forecast to a readjusted size of US$ 872 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 79
USD 4250.00
(Single User License)
Global AAV Vector Transfection Kits Market Research Report 2025
The global market for AAV Vector Transfection Kits was valued at US$ 177 million in the year 2024 and is projected to reach a revised size of US$ 872 million by 2031, growing at a CAGR of 25.9% during the forecast period.
Published Date: 2025-08-27
Pages: 86
USD 2900.00
(Single User License)
AAV Vector Transfection Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 128 million in 2024 and is forecast to a readjusted size of US$ 628 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 108
USD 3950.00
(Single User License)
AAV Vector Transfection Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research.
Published Date: 2024-01-18
Pages: 96
USD 3950.00
(Single User License)
Global AAV Vector Transfection Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AAV Vector Transfection Kits market size was US$ 219 million in 2025 and is forecast to reach a readjusted size of US$ 1076 million by 2032 with a CAGR of 25.9% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 76
USD 4250.00 (Single User License)Global AAV Vector Transfection Kits Market Research Report 2026
The global AAV Vector Transfection Kits market was valued at US$ 219 million in 2025 and is anticipated to reach US$ 1076 million by 2032, at a CAGR of 25.9% from 2026 to 2032.
Published: 2026-01-05
Pages: 108
USD 2900.00 (Single User License)AAV Vector Transfection Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 219 million in 2025 and is projected to reach US$ 1076 million, growing at a CAGR of 25.9% from 2026 to 2032.
Published: 2026-01-05
Pages: 108
USD 3950.00 (Single User License)AAV Vector Transfection Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 177 million in 2024 and is forecast to a readjusted size of US$ 872 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 102
USD 3950.00 (Single User License)Global AAV Vector Transfection Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AAV Vector Transfection Kits market size was US$ 177 million in 2024 and is forecast to a readjusted size of US$ 872 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 79
USD 4250.00 (Single User License)Global AAV Vector Transfection Kits Market Research Report 2025
The global market for AAV Vector Transfection Kits was valued at US$ 177 million in the year 2024 and is projected to reach a revised size of US$ 872 million by 2031, growing at a CAGR of 25.9% during the forecast period.
Published: 2025-08-27
Pages: 86
USD 2900.00 (Single User License)AAV Vector Transfection Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AAV Vector Transfection Kits was estimated to be worth US$ 128 million in 2024 and is forecast to a readjusted size of US$ 628 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 108
USD 3950.00 (Single User License)AAV Vector Transfection Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research.
Published: 2024-01-18
Pages: 96
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now